inSoma Bio

Durham, NC · Founded 2018 · Privately Held (backing)

Developer of bioengineered reconstructive biomaterials designed to enable the use of a person's tissue in surgical procedures. inSoma Bio is based in Durham, NC and was founded in 2018. Its last reported valuation was $18.7 million in May 2024. It has raised $7.8 million across 3 recorded rounds; the latest was a $2.7 million seed round in Sep 2025.

Last reported valuation
$18.7M
Oct 2026
Priced at
—
Total raised
$7.8M
Last round
Seed Round
Sep 2025
Cap table — not yet on record

inSoma Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of inSoma Bio with a free account
  • ·The complete investor list: 23 names
  • ·Watch inSoma Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about inSoma Bio

Where does inSoma Bio's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across inSoma Bio's 3 recorded funding rounds.